Call for Paper:
Track: 3 Breast Pathology
SUB TRACK Breast pathology, Cancer, Breast Cancer, spherulosis, metaplasia, Adenosis, sclerosing, adenosis, skin cancer cancer diagnose breast skin, nipple, scaling, ovarian cancer. Carcinoma, epithelial cells, adenocarcinoma, Atypical Hyperplasia, Ductal Carcinoma, Lung Cancer Skin Cancer Head and Neck Cancers, Nasopharyngeal Cancer Cervical, Cancer Endometrial, Cancer Ovarian Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer, Uterine Sarcoma, Vaginal Cancer, Vulvar Cancer,
Breast pathology is a branch of pathology that focuses on both benign and malignant disorders of the breast. The assessment of the axillary lymph nodes falls under this category.
Adenosis, sclerosing adenosis, apocrine metaplasia, cysts, collagenous spherulosis, duct ectasia, columnar alteration with prominent apical snouts and secretions (CAPSS), papillomatosis, or fibrocystic alterations are examples of benign (non-cancer) breast abnormalities.
Pathologists are medical professionals that focus on diagnosing illnesses by examining tissue and cells, frequently under a microscope. A breast pathologist will produce a report that summarises the diagnosis after studying breast tissue and cells. You might be given a breast cancer diagnosis at this moment.
Types of Breast Cancer
In situ ductal carcinoma (DCIS)
Ductal carcinoma in situ (DCIS) is a type of non-invasive cancer in which the lining of the breast milk duct has been found to contain abnormal cells. The surrounding breast tissue has not been invaded by the abnormal cells that have left the ducts. Ductal carcinoma in situ is a relatively curable, early-stage cancer that has the potential to spread to the breast tissue if ignored or undiagnosed.
Invasive Ductal Carcinoma (IDC)
With invasive ductal carcinoma (IDC), aberrant cancer cells that initially developed in the milk ducts have moved outside of the ducts and into other tissues of the breast. Cancer cells that are invasive can also spread to different body regions. Additionally known as infiltrative ductal carcinoma.
Lobular Carcinoma In Situ (LCIS)
A condition known as lobular carcinoma in situ (LCIS) occurs when abnormal cells are discovered in the breast’s lobules. The surrounding breast tissue has not been invaded by the abnormal cells outside of the lobules.
LCIS seldom develops into invasive carcinoma and is very curable. However, if you have LCIS in one breast, you’re more likely to get breast cancer in either breast.
Invasive Lobular Cancer (ILC)
invasive breast cancer that starts in the breast’s lobules (milk glands) and spreads to nearby healthy tissue. It can also spread to different body areas via the lymphatic and blood systems.
The second most frequent form of breast cancer is invasive lobular. Invasive lobular carcinomas make up more than 10% of all invasive breast cancers.
Triple Negative Breast Cancer
The three most prevalent types of receptors known to fuel the majority of breast cancer growth—estrogen, progesterone, and the HER-2/neu gene—are not present in the cancer tumour when breast cancer is diagnosed as triple negative. This indicates that tests for the hormone receptors HER-2, ER, and progesterone receptors on breast cancer cells have come back negative (PR).
Inflammatory Breast Cancer (IBC)
Breast cancer that has invaded the epidermis and lymphatic vessels of the breast is referred to as inflammatory breast cancer. It frequently results in no clear tumour or lump that is localised in the breast and can be felt. However, symptoms start to show up when the breast cancer cells obstruct the lymph veins.
Metastatic Breast Cancer
Breast cancer in Stage 4 also includes metastatic disease. Other bodily areas have been affected by the cancer’s spread. Typically, this involves the brain, bones, liver, lungs, or liver.